3,250
Views
25
CrossRef citations to date
0
Altmetric
Original Articles

Combined therapeutic effects of HIFU, GnRH-a and LNG-IUS for the treatment of severe adenomyosis

, , , &
Pages 485-491 | Received 11 Dec 2018, Accepted 10 Mar 2019, Published online: 17 Apr 2019

References

  • Taneichi A, Fujiwara H, Takahashi Y, et al. Influences of uterine adenomyosis on muscle invasion and prognosis of endometrioid adenocarcinoma. Int J Gynecol Cancer. 2014;24:1429–1433.
  • Gordts S, Grimbizis G, Campo R. Symptoms and classification of uterine adenomyosis, including the place of hysteroscopy in diagnosis. Fertil Steril. 2018;109:380–388.e1.
  • Grimbizis GF, Mikos T, Tarlatzis B. Uterus-sparing operative treatment for adenomyosis. Fertil Steril. 2014;101:472–487.
  • Sheth SS, Ray SS. Severe adenomyosis and CA125. J Obstet Gynaecol. 2014;34:79–81.
  • Abbott JA. Adenomyosis and Abnormal Uterine Bleeding (AUB-A)-pathogenesis, diagnosis, and management. Best Prac Res Clin Obstet Gynaecol. 2017;40:68–81.
  • Hulka CA, Hall DA, McCarthy K, et al. Sonographic findings in patients with adenomyosis: can sonography assist in predicting extent of disease? Am J Roentgenol. 2002;179:379–383.
  • Tsui KH, Lee WL, Chen CY, et al. Medical treatment for adenomyosis and/or adenomyoma. Taiwan J Obstet Gynecol. 2014;53:459–465.
  • Dueholm M. Minimally invasive treatment of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2018;51:119–137.
  • Zhang L, Rao F, Setzen R. High intensity focused ultrasound for the treatment of adenomyosis: selection criteria, efficacy, safety and fertility. Acta Obstet Gynecol Scand. 2017;96:707–714.
  • Elhelf IAS, Albahar H, Shah U, et al. High intensity focused ultrasound: the fundamentals, clinical applications and research trends. Diagn Interv Imaging. 2018;99:349–359.
  • Liu X, Wang W, Wang Y, et al. Clinical predictors of long-term success in ultrasound-guided high-intensity focused ultrasound ablation treatment for adenomyosis: a retrospective study. Medicine. 2016;95:e2443.
  • Shui L, Mao S, Wu Q, et al. High-intensity focused ultrasound (HIFU) for adenomyosis: two-year follow-up results. Ultrason Sonochem. 2015;27:677–681.
  • Rickes D, Nickel I, Kropf S, et al. Increased pregnancy rates after ultralong postoperative therapy with gonadotropin-releasing hormone analogs in patients with endometriosis. Fertil Steril. 2002;78:757–762.
  • Grandi G, Farulla A, Sileo FG, et al. Levonorgestrel-releasing intra-uterine systems as female contraceptives. Exp Opin Pharmacother. 2018;19:677–686.
  • Zhang P, Song K, Li L, et al. Efficacy of combined levonorgestrel-releasing intrauterine system with gonadotropin-releasing hormone analog for the treatment of adenomyosis. Med Princ Pract. 2013;22:480–483.
  • Aicher B, Peil H, Peil B, et al. Pain measurement: visual analogue scale (VAS) and verbal rating scale (VRS) in clinical trials with OTC analgesics in headache. Cephalalgia. 2012;32:185–197.
  • Higham JM, O’Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol. 1990;97:734–739.
  • Cho S, Nam A, Kim H, et al. Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis. Am J Obstet Gynecol. 2008;198:373.e1–377.
  • Osada H. Uterine adenomyosis and adenomyoma: the surgical approach. Fertil Steril. 2018;109:406–417.
  • Zhou M, Chen JY, Tang LD, et al. Ultrasound-guided high-intensity focused ultrasound ablation for adenomyosis: the clinical experience of a single center. Fertil Steril. 2011;95:900–905.
  • Khan KN, Kitajima M, Hiraki K, et al. Cell proliferation effect of GnRH agonist on pathological lesions of women with endometriosis, adenomyosis and uterine myoma. Hum Reprod. 2010;25:2878–2890.
  • Rose S, Chaudhari A, Peterson CM. Mirena (Levonorgestrel intrauterine system): a successful novel drug delivery option in contraception. Adv Drug Deliv Rev. 2009;61:808–812.
  • Mu Y, Hu X, He J, et al. Serum levels of vascular endothelial growth factor and cancer antigen 125 are related to the prognosis of adenomyosis patients after interventional therapy. Int J Clin Exp Med. 2015;8:9549–9554.
  • Kil K, Chung JE, Pak HJ, et al. Usefulness of CA125 in the differential diagnosis of uterine adenomyosis and myoma. Eur J Obstet Gynecol Reprod Biol. 2015;185:131–135.